Current:Home > StocksChairperson of Alabama’s medical marijuana commission steps down -AssetTrainer
Chairperson of Alabama’s medical marijuana commission steps down
View
Date:2025-04-13 09:44:16
MONTGOMERY, Ala. (AP) — The chairperson of the Alabama Medical Cannabis Commission stepped down on Thursday after a lawsuit challenged his eligibility to serve on the board.
Dr. Steven Stokes, a radiation oncologist from Dothan, Alabama, submitted his resignation Thursday from the commission tasked with regulating medical marijuana providers in the state.
“Dr. Stokes has a genuine desire to see medical cannabis products available to patients in Alabama. ... We greatly appreciate Dr. Stokes’ contribution to the Commission and anticipate that he will remain at the forefront of the development of Alabama’s medical cannabis program,” a spokesperson for the commission wrote in an email.
The statement from the commission did not give a reason for the resignation.
A lawsuit filed last month challenged Stokes’ eligibility to serve on the commission since he also serves as a trustee for the University of South Alabama. State law says public officials, lobbyists and candidates for public office cannot serve on the board.
The Alabama Medical Cannabis Commission in June pulled back licenses that had been awarded to cultivators, dispensaries and others after discovering potential problems with how applicants were scored.
Brittany Peters, a spokesperson for the commission, said the board is scheduled to re-award licenses and restart the procedural timelines associated with the licensing process at its meeting on Aug. 10.
Alabama lawmakers in 2021 ended years of resistance and approved the creation of a program to allow marijuana to be used for certain medical conditions. However, it is not available yet to patients as the state develops rules and procedures for the program.
veryGood! (177)
Related
- Pressure on a veteran and senator shows what’s next for those who oppose Trump
- Indian official won’t confirm a reported meeting of ministers over Sikh leader’s killing in Canada
- US arranging evacuation flights for Americans who want to leave Israel as war with Hamas rages
- Instead of embracing FBI's 'College Basketball Columbo,' NCAA should have faced reality
- Rolling Loud 2024: Lineup, how to stream the world's largest hip hop music festival
- Finnish intelligence says Russia views Finland as a hostile nation due to its NATO membership
- Taiwan is closely watching the Hamas-Israel war for lessons as it faces intimidation from China
- By The Way, Here's That Perfect T-Shirt You've Been Looking For
- US wholesale inflation accelerated in November in sign that some price pressures remain elevated
- US aircraft carrier arrives in South Korea as North’s leader Kim exchanges messages with Putin
Ranking
- Tarte Shape Tape Concealer Sells Once Every 4 Seconds: Get 50% Off Before It's Gone
- Why Russia is engaged in a delicate balancing act in the Israel-Hamas war
- Ex-Barclays Bank boss Staley banned from senior UK finance roles over misleading Epstein statements
- WNBA Finals: Aces leave Becky Hammon 'speechless' with Game 2 domination of Liberty
- Nevada attorney general revives 2020 fake electors case
- Harvard student groups doxxed after signing letter blaming Israel for Hamas attack
- Arrest made after 3 stabbed at Atlanta airport, including police officer
- Russian President Putin arrives in Kyrgyzstan on a rare trip abroad
Recommendation
Sarah J. Maas books explained: How to read 'ACOTAR,' 'Throne of Glass' in order.
Josh Duggar to Remain in Prison Until 2032 After Appeal in Child Pornography Case Gets Rejected
Norway activists press on with their protest against wind farm on land used by herders
'Walk the talk' or face fines: EU boss tells Musk, Zuckerberg and Tik Tok chief
Who are the most valuable sports franchises? Forbes releases new list of top 50 teams
UN suspends and detains 8 peacekeepers in Congo over allegations of sexual exploitation
US inflation may have risen only modestly last month as Fed officials signal no rate hike is likely
EU orders biotech giant Illumina to unwind $7.1 billion purchase of cancer-screening company Grail